Literature DB >> 32508367

Case Report: A Case of Intellectual Disability with Inappropriate and Challenging Sexual Behavior that was Treated with GNRH Analogues.

Ferhat Yaylacı1, Ali Gül1.   

Abstract

Intellectual Disability starts within the course of developmental stages and covers both intellectual and adaptive deficiencies in conceptual, social and applied fields. Individuals with intellectual disability experience many difficulties in social life due to challenging and inappropriate sexual behaviour. Suchdifficulties need to be addressed, reduced or treated. Traditional treatments often fail to treat and improve suchbehavior. Alternative treatment options need to be explored with studies conducted in this field. With this paper, we aimed to show and touch on alternative treatments for challenging and inappropriate behaviors of a 15-year old boy with intellectual disability, who was treated with GNRH analogues.
Copyright © 1964–2019 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States.

Entities:  

Keywords:  GNRH analogues; inappropriate and challenging sexual behavior; intellectual disability

Mesh:

Substances:

Year:  2020        PMID: 32508367      PMCID: PMC7255840     

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  11 in total

Review 1.  Antipsychotic medication for challenging behaviour in people with learning disability.

Authors:  J Brylewski; L Duggan
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 2.  Assessing psychopathology in individuals with developmental disabilities.

Authors:  Karena S Rush; Lynn G Bowman; Shannon L Eidman; Lisa M Toole; Bruce P Mortenson
Journal:  Behav Modif       Date:  2004-09

3.  Case Report: Resolution of Severe Sexual Aggression in a Developmentally Disabled Adolescent During Leuprolide Acetate Use.

Authors:  Cara Fosdick; Sarah Mohiuddin
Journal:  J Autism Dev Disord       Date:  2016-06

4.  Sexual behaviors in autism: problems of definition and management.

Authors:  G M Realmuto; L A Ruble
Journal:  J Autism Dev Disord       Date:  1999-04

5.  Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: prevalence and reasons for prescription.

Authors:  Gerda de Kuijper; P Hoekstra; F Visser; F A Scholte; C Penning; H Evenhuis
Journal:  J Intellect Disabil Res       Date:  2010-04-20

6.  A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders.

Authors:  David A Geier; Mark R Geier
Journal:  Neuro Endocrinol Lett       Date:  2006-12       Impact factor: 0.765

7.  A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies.

Authors:  David A Geier; Mark R Geier
Journal:  Neuro Endocrinol Lett       Date:  2007-10       Impact factor: 0.765

8.  Referral trends of people with intellectual disabilities and psychiatric disorders.

Authors:  N Bouras; A Cowley; G Holt; J T Newton; P Sturmey
Journal:  J Intellect Disabil Res       Date:  2003-09

9.  Gonadotropin-releasing hormone agonist against severe aggression in autism.

Authors:  Robin M F van der Weiden; Frans M Helmerhorst; Tomas Eriksson
Journal:  BMJ Case Rep       Date:  2016-09-21

10.  Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial.

Authors:  Peter Tyrer; Patricia C Oliver-Africano; Zed Ahmed; Nick Bouras; Sherva Cooray; Shoumitro Deb; Declan Murphy; Monica Hare; Michael Meade; Ben Reece; Kofi Kramo; Sabyasachi Bhaumik; David Harley; Adrienne Regan; David Thomas; Bharti Rao; Bernard North; Joseph Eliahoo; Shamshad Karatela; Anju Soni; Mike Crawford
Journal:  Lancet       Date:  2008-01-05       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.